94 related articles for article (PubMed ID: 31347000)
1. Prevalence and Determinants of High-risk HPV Infection among 11549 Women from an Opportunistic Screening in Hubei Province.
Ma QF; Guo YL; Gao H; Yan B; Dai X; Xu M; Xiong YJ; Peng QZ; Wang Y; Zou M; Wu XF
Curr Med Sci; 2019 Aug; 39(4):622-630. PubMed ID: 31347000
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with high-risk human papillomavirus infection and high-grade cervical neoplasia: A population-based study in Paraguay.
Kasamatsu E; Rodríguez Riveros MI; Soilan AM; Ortega M; Mongelós P; Páez M; Castro A; Cristaldo C; Báez FR; Centurión CC; Vester J; Barrios H; Villalba G; Amarilla ML; Giménez G; Caubere E; Hernández ML; Baena A; Almonte M; Herrero R; Mendoza LP;
PLoS One; 2019; 14(6):e0218016. PubMed ID: 31246959
[TBL] [Abstract][Full Text] [Related]
3. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
[TBL] [Abstract][Full Text] [Related]
4. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Associated Factors of Abnormal Cervical Cytology and HighRisk HPV DNA among Bangkok Metropolitan Women.
Tangjitgamol S; Kantathavorn N; Kittisiam T; Chaowawanit W; Phoolcharoen N; Manusirivithaya S; Khunnarong J; Srijaipracharoen S; Saeloo S; Krongthong W; Supawattanabodee B; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(7):3147-53. PubMed ID: 27509943
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women.
Winer RL; Hughes JP; Feng Q; Xi LF; Lee SK; O'Reilly SF; Kiviat NB; Koutsky LA
Sex Transm Dis; 2012 Nov; 39(11):848-56. PubMed ID: 23064533
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.
Tay SK; Oon LL
Int J STD AIDS; 2014 Dec; 25(14):1013-21. PubMed ID: 24648316
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with high-risk HPV infection and cervical cancer screening methods among rural Uyghur women aged > 30 years in Xinjiang.
Husaiyin S; Han L; Wang L; Ma C; Ainiwaer Z; Rouzi N; Akemujiang M; Simayil H; Aniwa Z; Nurimanguli R; Niyazi M
BMC Cancer; 2018 Nov; 18(1):1162. PubMed ID: 30470207
[TBL] [Abstract][Full Text] [Related]
10. Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study.
Alberts CJ; Vos RA; Borgdorff H; Vermeulen W; van Bergen J; Bruisten SM; Geerlings SE; Snijder MB; van Houdt R; Morré SA; de Vries HJ; van de Wijgert JH; Prins M; Schim van der Loeff MF
Sex Transm Infect; 2016 Dec; 92(8):611-618. PubMed ID: 27188273
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus type 18/16 infection and prevalence among middle-aged and older Chinese rural women: a cross-sectional survey in Wufeng, Hubei Province.
Yu Q; Liu Q; Gao Y; Gong H; Tan X; Zhang M; Tuo J; Zhang Y; Xiang Q; Deng F; Liu G
Women Health; 2019; 59(10):1105-1117. PubMed ID: 30917772
[TBL] [Abstract][Full Text] [Related]
12. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
13. Classical HLA alleles are associated with prevalent and persistent cervical high-risk HPV infection in African women.
Adebamowo SN; Adeyemo AA;
Hum Immunol; 2019 Sep; 80(9):723-730. PubMed ID: 31072753
[TBL] [Abstract][Full Text] [Related]
14. Independent risk factors for high-risk human papillomavirus infection among rural women in Shanxi Province, China: a population-based, case-control study.
Shi R; Qi W; Cai J; Zhao M; Wang Z
Arch Gynecol Obstet; 2023 Aug; 308(2):551-559. PubMed ID: 36814027
[TBL] [Abstract][Full Text] [Related]
15. The ideal strategy for cervical cancer screening in Japan: Result from the Fukui Cervical Cancer Screening Study.
Kurokawa T; Onuma T; Shinagawa A; Chino Y; Kobayashi M; Yoshida Y
Cytopathology; 2018 Aug; 29(4):361-367. PubMed ID: 29768678
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
17. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Ladelund S; Storgaard M; Katzenstein TL; Johansen IS; Pedersen G; Rönsholt FF; Nielsen LN; Nilas L; Franzmann M; Obel N; Lebech AM; Bonde J
BMC Infect Dis; 2019 Aug; 19(1):740. PubMed ID: 31438877
[TBL] [Abstract][Full Text] [Related]
18. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana.
Castle PE; Varallo JE; Bertram MM; Ratshaa B; Kitheka M; Rammipi K
PLoS One; 2020; 15(2):e0229086. PubMed ID: 32053659
[TBL] [Abstract][Full Text] [Related]
19. High-risk human papillomaviruses distribution in Romanian women with negative cytology.
Plesa A; Socolov D; Huica I; Botezatu A; Iancu IV; Ungureanu C; Teleman S; Albulescu A; Fudulu A; Anton G
J Infect Dev Ctries; 2019 Apr; 13(4):326-333. PubMed ID: 32045377
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana.
Krings A; Dunyo P; Pesic A; Tetteh S; Hansen B; Gedzah I; Wormenor CM; Amuah JE; Behnke AL; Höfler D; Pawlita M; Kaufmann AM
PLoS One; 2019; 14(6):e0218762. PubMed ID: 31246997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]